Antiplatelet and Anticoagulation Impact on Patients with Lower Extremity Arteriovenous Dialysis Access

Key Points

• Bleeding risk significantly increases with anticoagulation in arteriovenous dialysis access patients, impacting outcomes.
• Patients receiving anticoagulants had a higher incidence of bleeding events compared to those on antiplatelet therapy.
• Analysis included patients with arteriovenous access, emphasizing the need for careful medication management.
• Findings highlight the importance of balancing antiplatelet and anticoagulation therapy in managing dialysis access complications.